A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.


Updates from The Motley Fool

Latest updates on Savient Pharmaceuticals, Inc. from Fool.com.
What's Fueling Savient's Run?

Savient Pharmaceuticals , already up 106% in August, has doubled again in September. What is fuel...

2 Biotechs Trouncing the Market

The biotech week kicked off with a bang, not because of any macro factors like a new Federal Rese...

Avoid These 2 Plunging Biotechs

The following video is part of our "Motley Fool Conversations" series, in which health-care edito...

5 of Last Week's Biggest Losers

There's never a shortage of losers in the stock market. Let's take a closer look at five of this ...

2 Stocks Stopping the Presses

You saw the headlines. You know your stock price made a big move. But what does that portend fo...

3 Biotechs Posting Big Moves

Big moves in biotech today as takeout attempts and trial results dominate the headlines. Let's ju...

Get Ready for the Bounce

"Don't catch a falling knife," as the old saw commands. (Pardon my mixing cutlery metaphors.) The...

Avoid This Biotech Stock

Each week, Motley Fool editors cull a top stock idea from the pitches made on CAPS, The Motley Fo...

7 Biotechs Near 52-Week Lows

If you're aiming to "buy low and sell high," then it makes infinite sense to start your search wi...

Why Did My Stock Just Die?

Your stock just took a nosedive -- but don't panic. First, let's see whether it had good reason t...



Stock Performance

View Interactive SVNTQ Charts
Sponsored by

Key Data Points

Primary metrics and data points about Savient Pharmaceuticals, Inc..
Current Price: $0.00
Prev Close: $0.00
Open: $0.00
Bid: $0.00
Ask: $0.00
Day's Range: $0.00 - $0.00
52wk Range: $0.00 - $0.00
Volume: 0
Avg Vol 0
Market Cap: $0
P/E (ttm): 0.00
EPS (ttm): $0.00
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Savient Pharmaceuticals, Inc..
CAPS Rating 2 out of 5
 
391 Outperform
33 Underperform
CAPS All Stars
 
58 Outperform
12 Underperform

How do you think Savient Pharmaceuticals, Inc. will perform against the market?



You pick for Savient Pharmaceuticals, Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Savient Pharmaceuticals, Inc..

A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.

  • Exchange: NASDAQOTH
  • Sector: Healthcare
  • Industry: Drug Makers